Home > Financial Ratios > HIKAL

HIKAL
Core EBITDA Growth

    Back to All Ratios
HIKAL is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for HIKAL
Please provide your vote to see the results

HIKAL Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 2.67-24.025.3618.42-7.83

What is the latest Core EBITDA Growth ratio of HIKAL ?

The latest Core EBITDA Growth ratio of HIKAL is 2.67 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar20242.67
Mar2023-24.02
Mar20225.36
Mar202118.42
Mar2020-7.83

How is Core EBITDA Growth of HIKAL Trending?

Years Core EBITDA Growth % Change
Mar2024 2.67
Positive
Mar2023 -24.02
Negative
Mar2022 5.36
-70.90
Mar2021 18.42
Positive
Mar2020 -7.83 -

Other Financial Ratios of HIKAL


Compare Core EBITDA Growth ratio of peers of HIKAL

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
HIKAL ₹5,119.4 Cr -0.2% 10.7% 50.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹432,948.0 Cr 0.3% 0.2% 46% Stock Analytics
DIVIS LABORATORIES ₹157,873.0 Cr -2.7% -0.1% 58.9% Stock Analytics
CIPLA ₹116,809.0 Cr -3% -8.6% 19% Stock Analytics
DR REDDYS LABORATORIES ₹103,963.0 Cr -0.1% -3.4% 7.2% Stock Analytics
ZYDUS LIFESCIENCES ₹98,173.2 Cr 0.8% 1.8% 48.1% Stock Analytics


HIKAL Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
HIKAL

-0.2%

10.7%

50.2%

SENSEX

-0.6%

2.3%

16.9%


You may also like the below Video Courses